CDH1 and prostate cancer: To test if loss of E-cadherin can modulate AR mediated transcription via altered β-catenin levels in prostate cancer cells, we specifically knocked down endogenous E-cadherin expression using small hair-pin RNA interference approaches in human prostate cancer cell lines.